Zynex Inc., a medical technology company specializing in non-invasive devices for pain management and rehabilitation, has voluntarily entered into a Chapter 11 court-supervised financial restructuring. The company announced it has secured new financing from its lenders, demonstrating their confidence in Zynex's business and recent positive changes. Zynex stated that its operations will continue as usual with no impact to patients, customers, or employees. More information about the restructuring process is available on the company's case website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zynex Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA48448) on December 16, 2025, and is solely responsible for the information contained therein.